Lpl Financial LLC 9 Meters Biopharma, Inc. Transaction History

Lpl Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.21 - $0.32 $2,100 - $3,200	10,000 Added 22.36%	54,720 $12,000
Q1 2022 May 16, 2022	SELL	$0.52 - $1.0 $520 - $1,000	-1,000 Reduced 2.19%	44,720 $27,000
Q3 2021 Nov 15, 2021	BUY	$1.03 - $1.41 $1,030 - $1,410	1,000 Added 2.24%	45,720 $59,000
Q2 2021 Aug 13, 2021	BUY	$1.04 - $1.5 $1,040 - $1,500	1,000 Added 2.29%	44,720 $49,000
Q1 2021 May 14, 2021	SELL	$0.84 - $2.16 $928 - $2,386	-1,105 Reduced 2.47%	43,720 $51,000
Q4 2020 Feb 12, 2021	BUY	$0.65 - $1.11 $29,136 - $49,755	44,825 New	44,825 $39,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.